Fulcrum Therapeutics
FULC
FULC
116 hedge funds and large institutions have $172M invested in Fulcrum Therapeutics in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 51 increasing their positions, 22 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.54% more ownership
Funds ownership: 97.28% → 97.82% (+0.54%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
53% less capital invested
Capital invested by funds: $366M → $172M (-$194M)
Holders
116
Holding in Top 10
1
Calls
$1.98M
Puts
$138K
Top Buyers
| 1 | +$7.53M | |
| 2 | +$6M | |
| 3 | +$3.08M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.63M |
| 5 |
BlackRock
New York
|
+$2.61M |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$14.3M | |
| 3 | -$5.6M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$4.6M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.73M |